CAUSEY CHRISTOPHER bought UTHR
July 25, 2025 · Form 4 insider transaction
CAUSEY CHRISTOPHER bought 1,190 shares of United Therapeutics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,190
Price
$0.00
Total value
N/A
InsiderCAUSEY CHRISTOPHER
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 25, 2025
Filing dateJuly 28, 2025
Shares owned after4,865
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.